Skip to content

Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric Patient

Department of Orthopedic Oncology, The First Affiliated Hospital of Sun Yat-sen University

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06162962
Enrollment
345
Registered
2023-12-08
Start date
2000-01-01
Completion date
2023-11-23
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower Limb Injury, Osteosarcoma, Outcome, Pediatric

Brief summary

Retrospective analysis of specific characteristics of complications and long-term oncological and function outcomes in lower-limb osteosarcoma pediatric patients.

Detailed description

Clinical and functional outcomes were compared based on age groups, surgical methods, type of prosthesis, and primary tumor location. Patients were divided into the Low-age group (≤10 years old) and the High-age group (\>10 years old). Overall Survival rate (OS), Progression-Free Survival rate (PFS), and prosthesis survival rate were assessed using Kaplan-Meier curves, and non-parametric survival analysis (log-rank test) was used for comparison. The incidence of complications, local relapse rate (LRR), metastasis rate, final limb-salvage and amputation rate, and Musculoskeletal Tumor Society (MSTS) score of different independent groups were further evaluated using χ2 test or Fisher's exact test, and t-test was employed to evaluate the measurement data.

Interventions

Retrospective analysis

Sponsors

Changye Zou
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed lower limb osteosarcoma patients under the age of 14; 2. Performing tumor resection treatment in our hospital; 3. There is complete clinical registration data available.

Exclusion criteria

1. Not undergoing surgical treatment in our hospital; 2. Age older than 14 years old; 3. No available clinical registration data or lost follow-up patients; 4. Non lower limb osteosarcoma patients.

Design outcomes

Primary

MeasureTime frameDescription
Overall Survival rate (OS)2000-2019Oncological outcomes
Progression-Free Survival rate (PFS)2000-2019Oncological outcomes
Local recurrence rate(LRR)2000-2019Oncological outcomes
Metastasis rate2000-2019Oncological outcomes
Final limb-salvage and amputation rate2000-2019Oncological outcomes
Prosthesis survival rate2000-2019Functional outcomes
Musculoskeletal Tumor Society (MSTS) score2000-2019Functional outcomes
Complications2000-2019Functional outcomes

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026